Leen Kawas officially out at Athira after investigation finds doctored research

Bothell-based biotech Athira Pharma (Nasdaq: ATHA) has officially moved on from Leen Kawas, the company's former CEO who was placed on temporary leave in June pending a review of her doctoral research while at Washington State University. The embattled biotech announced Kawas was resigning from both her roles as CEO and president, as well as from her position on the company's board of directors. Mark Litton, who had been the chief operating officer before taking over day-to-day leadership when Kawas…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news